Silence Therapeutics plc announced that the European Patent Office (EPO) has granted a new patent that provides broad protection on novel aspects of the RNAi structural modification technology known as the “Zamore Design Rules.” European patent number 1 633 890 titled "Methods and Compositions for more
To use all functions of this page, please activate cookies in your browser.
